10x Genomics EBITDA 2018-2025 | TXG

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

10x Genomics ebitda from 2018 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

10x Genomics ebitda from 2018 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$47.6B
Hims & Hers Health (HIMS)	$12.8B
Doximity (DOCS)	$11.4B
Tempus AI (TEM)	$11B
IRhythm Technologies (IRTC)	$4.2B
Inspire Medical Systems (INSP)	$3.8B
Hinge Health (HNGE)	$3.6B
Privia Health (PRVA)	$2.4B
Schrodinger (SDGR)	$1.7B
Phreesia (PHR)	$1.6B
Clover Health Investments (CLOV)	$1.6B
Azenta (AZTA)	$1.6B
Enovis (ENOV)	$1.6B
Omnicell (OMCL)	$1.3B
Evolent Health (EVH)	$1.1B
Claritev (CTEV)	$686M
Fulgent Genetics (FLGT)	$560M
Standard BioTools (LAB)	$558M
Veradigm (MDRX)	$523M
Butterfly Network (BFLY)	$514M
Talkspace (TALK)	$422M
TruBridge (TBRG)	$349M
Outset Medical (OM)	$312M
Health Catalyst (HCAT)	$268M
Nyxoah SA (NYXH)	$265M
SOPHiA GENETICS SA (SOPH)	$241M
CapsoVision (CV)	$198M
Zepp Health (ZEPP)	$165M
KORU Medical Systems (KRMD)	$162M
American Well (AMWL)	$136M